This inventor holds 6 USPTO granted patents and 8 published patent applications, plus 1 CIPO patent and 3 EPO patents. Top assignees: Merck Sharp + Dohme Corp., Akebia Therapeutics, Inc.. Active years: 2017-2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2017-2023
Title: The Innovations of Gurudatt Ajay Chandorkar
Introduction
Gurudatt Ajay Chandorkar is a notable inventor based in Waltham, MA, with a significant contribution to the field of medicine. He holds a total of six patents, showcasing his dedication to advancing healthcare solutions. His work primarily focuses on innovative treatments for anemia, particularly in patients with chronic conditions.
Latest Patents
Chandorkar's latest patents include compositions and methods for treating anemia. These patents detail specific doses and dosing regimens for using a HIF prolyl hydroxylase inhibitor to treat or prevent anemia. This includes anemia secondary to chronic kidney disease, non-dialysis dependent chronic kidney disease, chemotherapy-related anemia, and anemia associated with AIDS. His research aims to provide effective solutions for patients suffering from these debilitating conditions.
Career Highlights
Throughout his career, Gurudatt has worked with prominent companies such as Merck Sharp & Dohme Corporation and Akebia Therapeutics, Inc. His experience in these organizations has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Some of his notable coworkers include Jennifer A Huntington and Tara Parsons. Their collaboration has likely played a role in the development of innovative solutions in the medical field.
Conclusion
Gurudatt Ajay Chandorkar's contributions to the treatment of anemia through his patents and collaborations highlight his commitment to improving patient care. His work continues to influence the medical community and offers hope for those affected by anemia.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

